These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22806699)

  • 1. [Local and systemic bone effects of rheumatoid arthritis].
    Rauner M; Hofbauer LC; Aringer M
    Z Rheumatol; 2012 Dec; 71(10):869-73. PubMed ID: 22806699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alfacalcidol versus plain vitamin D in inflammation induced bone loss.
    Scharla SH; Schacht E; Lempert UG
    J Rheumatol Suppl; 2005 Sep; 76():26-32. PubMed ID: 16142848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.
    Ringe JD; Faber H; Fahramand P; Schacht E
    J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of osteoporosis in rheumatoid arthritis patients.
    Hoes JN; Bultink IE; Lems WF
    Expert Opin Pharmacother; 2015 Mar; 16(4):559-71. PubMed ID: 25626121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal complications of rheumatoid arthritis.
    Heinlen L; Humphrey MB
    Osteoporos Int; 2017 Oct; 28(10):2801-2812. PubMed ID: 28779302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of osteoporosis and rheumatoid arthritis in accordance with German guidelines. Results of a survey of patients, primary care physicians and rheumatologists].
    Heberlein I; Demary W; Bloching H; Braun J; Buttgereit F; Dreher R; Kuhn C; Lange U; Zink A; Zeidler H; Häntzschel H; Raspe H
    Z Rheumatol; 2011 Sep; 70(7):592-601. PubMed ID: 21755301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calcium and vitamin D preparations in steroid osteoporosis in patients with rheumatoid arthritis].
    Bazhenov AN; Plesovskaia IV; Iliushina LV
    Ter Arkh; 2007; 79(5):89-92. PubMed ID: 17672084
    [No Abstract]   [Full Text] [Related]  

  • 8. Strategies for the prevention and treatment of osteoporosis in patients with rheumatoid arthritis.
    Phillips K; Aliprantis A; Coblyn J
    Drugs Aging; 2006; 23(10):773-9. PubMed ID: 17067181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide.
    Raterman HG; Lems WF
    Drugs Aging; 2019 Dec; 36(12):1061-1072. PubMed ID: 31541358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis.
    Edwards CJ; Williams E
    Osteoporos Int; 2010 Aug; 21(8):1287-93. PubMed ID: 20229200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone safety of low-dose glucocorticoids in rheumatic diseases.
    Saag KG
    Ann N Y Acad Sci; 2014 May; 1318():55-64. PubMed ID: 24815076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis, clinical feature and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis].
    Nakayama H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():499-503. PubMed ID: 18161156
    [No Abstract]   [Full Text] [Related]  

  • 13. [Secondary osteoporosis UPDATE. Rheumatoid arthritis and bone damage: trends in treatment].
    Tanaka Y
    Clin Calcium; 2010 May; 20(5):735-42. PubMed ID: 20445285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction. D-hormones alfacalcidol and calcitriol for prevention and treatment of glucocorticoid/inflammation-induced osteoporosis.
    Sambrook PN; Schacht E
    J Rheumatol Suppl; 2005 Sep; 76():1-3. PubMed ID: 16142844
    [No Abstract]   [Full Text] [Related]  

  • 15. [Generalized osteoporosis in chronic polyarthritis--pathomechanisms and treatment approaches].
    Ringe JD
    Z Rheumatol; 1996; 55(3):149-57. PubMed ID: 8768144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Anti-bone resorbing treatment for rheumatoid arthritis.].
    Tanaka Y
    Clin Calcium; 2018; 28(5):630-636. PubMed ID: 29731457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis in patients with rheumatoid arthritis: an update in epidemiology, pathogenesis, and fracture prevention.
    Raterman HG; Bultink IE; Lems WF
    Expert Opin Pharmacother; 2020 Oct; 21(14):1725-1737. PubMed ID: 32605401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients.
    Xie J; Li S; Xiao L; Ouyang G; Zheng L; Gu Y; Gao C; Han X
    J Orthop Surg Res; 2019 Dec; 14(1):421. PubMed ID: 31823822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of osteoporosis development in patients with rheumatoid arthritis].
    Matuszewska A; Szechiński J
    Postepy Hig Med Dosw (Online); 2014 Feb; 68():145-52. PubMed ID: 24491906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating and mitigating fracture risk in established rheumatoid arthritis.
    Mullen MB; Saag KG
    Best Pract Res Clin Rheumatol; 2015; 29(4-5):614-27. PubMed ID: 26697770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.